Michael Hearne - Jan 12, 2022 Form 4 Insider Report for LA JOLLA PHARMACEUTICAL CO (LJPC)

Role
Chief Financial Officer
Signature
/s/ Michael Hearne
Stock symbol
LJPC
Transactions as of
Jan 12, 2022
Transactions value $
$0
Form type
4
Date filed
1/14/2022, 05:27 PM
Previous filing
Jan 4, 2022
Next filing
Jan 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LJPC Employee Stock Option (Right to Buy) Award $0 +78.6K $0.00 78.6K Jan 12, 2022 Common Stock 78.6K $4.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.